• Je něco špatně v tomto záznamu ?

Short term methylphenidate treatment does not increase myocardial injury in the ischemic rat heart

S. L. Seeley, M. S. D'Souza, T. S. Stoops, B. R. Rorabaugh

. 2020 ; 69 (5) : 803-812. [pub] 20200529

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21028137

Grantová podpora
R15 HL145546 NHLBI NIH HHS - United States

Methylphenidate is commonly used for the treatment of attention deficit hyperactivity disorder. The cardiovascular safety of methylphenidate has been a subject of debate with some studies indicating that methylphenidate increases the likelihood of experiencing a myocardial infarction. However, it is unknown whether methylphenidate worsens the extent of injury during an ischemic insult. The purpose of this study was to determine whether short term exposure to methylphenidate increases the extent of myocardial injury during an ischemic insult. Male and female rats received methylphenidate (5 mg/kg/day) or saline for 10 days by oral gavage. Hearts were subjected to 20 min of ischemia and 2 h of reperfusion on a Langendorff isolated heart apparatus on day 11. Cardiac contractile function was monitored via an intraventricular balloon and myocardial injury was assessed by triphenyltetrazolium chloride staining. Methylphenidate significantly increased locomotor activity in male and female rats, confirming absorption of this psychostimulant into the central nervous system. Male hearts had significantly larger infarcts than female hearts, but methylphenidate had no impact on infarct size or postischemic recovery of contractile function in hearts of either sex. These data indicate that methylphenidate does not increase the extent of injury induced by an ischemic insult.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21028137
003      
CZ-PrNML
005      
20211129135920.0
007      
ta
008      
211105s2020 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934368 $2 doi
035    __
$a (PubMed)32469230
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Seeley, S. L. $u Ohio Northern University School of Pharmacy, Ada, OH, USA
245    10
$a Short term methylphenidate treatment does not increase myocardial injury in the ischemic rat heart / $c S. L. Seeley, M. S. D'Souza, T. S. Stoops, B. R. Rorabaugh
504    __
$a Literatura
520    9_
$a Methylphenidate is commonly used for the treatment of attention deficit hyperactivity disorder. The cardiovascular safety of methylphenidate has been a subject of debate with some studies indicating that methylphenidate increases the likelihood of experiencing a myocardial infarction. However, it is unknown whether methylphenidate worsens the extent of injury during an ischemic insult. The purpose of this study was to determine whether short term exposure to methylphenidate increases the extent of myocardial injury during an ischemic insult. Male and female rats received methylphenidate (5 mg/kg/day) or saline for 10 days by oral gavage. Hearts were subjected to 20 min of ischemia and 2 h of reperfusion on a Langendorff isolated heart apparatus on day 11. Cardiac contractile function was monitored via an intraventricular balloon and myocardial injury was assessed by triphenyltetrazolium chloride staining. Methylphenidate significantly increased locomotor activity in male and female rats, confirming absorption of this psychostimulant into the central nervous system. Male hearts had significantly larger infarcts than female hearts, but methylphenidate had no impact on infarct size or postischemic recovery of contractile function in hearts of either sex. These data indicate that methylphenidate does not increase the extent of injury induced by an ischemic insult.
650    _2
$a zvířata $7 D000818
650    _2
$a stimulanty centrálního nervového systému $x farmakologie $7 D000697
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a rozvrh dávkování léků $7 D004334
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methylfenidát $x škodlivé účinky $x farmakologie $7 D008774
650    _2
$a kontrakce myokardu $x účinky léků $7 D009200
650    _2
$a infarkt myokardu $x chemicky indukované $x patologie $7 D009203
650    _2
$a ischemická choroba srdeční $x chemicky indukované $x patologie $7 D017202
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Sprague-Dawley $7 D017207
650    _2
$a obnova funkce $7 D020127
655    _2
$a časopisecké články $7 D016428
700    1_
$a D'Souza, M. S. $u Ohio Northern University School of Pharmacy, Ada, OH, USA
700    1_
$a Stoops, T. S. $u Ohio Northern University School of Pharmacy, Ada, OH, USA
700    1_
$a Rorabaugh, B. R. $u Marshall University School of Pharmacy, Huntington, WV, USA
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 69, č. 5 (2020), s. 803-812
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32469230 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20211105 $b ABA008
991    __
$a 20211122150445 $b ABA008
999    __
$a ok $b bmc $g 1728746 $s 1148682
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 69 $c 5 $d 803-812 $e 20200529 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
GRA    __
$a R15 HL145546 $p NHLBI NIH HHS $2 United States
LZP    __
$b NLK118 $a Pubmed-20211105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...